Skip Navigation


Journal of Intellectual Property Law & Practice Advance Access originally published online on October 11, 2006
Journal of Intellectual Property Law & Practice 2006 1(12):748-749; doi:10.1093/jiplp/jpl168
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1/12/748    most recent
jpl168v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bucknell, D.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press. All rights reserved

Current Intelligence

Improper claim dependency invalidates US Lipitor patent

Duncan Bucknell
IP Strategy Consultant, www.DuncanBucknell.com

The US Court of Appeals for the Federal Circuit has confirmed that a patent claim may be invalidated for what was previously considered to be a minor technical defect: in essence, a dependent claim is invalid if it is not a subset of the claim from which it purports to depend. While Ranbaxy succeeded on this point, its generic Lipitor product was still held to have infringed Pfizer's enantiomer patent, which expires on 24 March 2010, with pediatric exclusivity.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.